Literature DB >> 6854274

Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.

W A Boere, B J Benaissa-Trouw, M Harmsen, C A Kraaijeveld, H Snippe.   

Abstract

Two monoclonal antibodies (UM 4.2 and UM 5.1) directed against the glycoprotein E2 of Semliki Forest virus (SFV) are described; both belong to the IgG2a isotype but are of different idiotype. Analysis employing isoelectric focusing resulted in different focusing patterns for both monoclonals (UM 4.2, pI 8; UM 5.1, pI 7.2). They further differed in their ability to neutralize virus. The UM 4.2 antibodies were inactive in neutralization, while the UM 5.1 antibodies exceeded conventional mouse hyperimmune serum in this respect. Both monoclonal antibodies, however, were able to protect mice passively from a lethal infection with SFV. Based on the amount of protein, the UM 5.1 antibodies were 100-fold more effective than the UM 4.2 antibodies in mouse protection tests.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854274     DOI: 10.1099/0022-1317-64-6-1405

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.

Authors:  F Vlaspolder; C A Kraaijeveld; R van Buuren; M Harmsen; B J Benaissa-Trouw; H Snippe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus.

Authors:  K Yokomori; S C Baker; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

Authors:  P A Offit; R D Shaw; H B Greenberg
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.

Authors:  W A Boere; M Harmsen; C A Kraaijeveld; H Snippe
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.

Authors:  Farinaz Safavi; Jason P Feliberti; Cedric S Raine; Foroozan Mokhtarian
Journal:  J Neuroimmunol       Date:  2011-05-25       Impact factor: 3.478

7.  Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies.

Authors:  F H van Tiel; W A Boere; T Harmsen; C A Kraaijeveld; H Snippe
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 8.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.

Authors:  F H van Tiel; T Harmsen; M Wagenaar; W A Boere; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 10.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.